Accessibility Menu
Tricida logo

Tricida(NASDAQ) TCDA

This security has been delisted. This page is retained for historical reference.

Tricida last closing stock price
MetricPriceDate
Last closeUSD 0.112023-01-23
Tricida stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-27.27%USD 0.152023-01-13
1 month-28.19%USD 0.152022-12-23
3 month-80.44%USD 0.552022-10-25
Year to date-29.37%USD 0.152022-12-30
1 year-98.77%USD 8.812022-01-21
3 year-99.68%USD 33.402020-01-24
Since inception-100%USD 26.002018-06-28

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

TCDA Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-355.98%

Return on Capital

-112.13%

Return on Assets

-115.23%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$123.92M

EBITDA

-$123.59M

Operating Cash Flow

-$108.79M

Capital Expenditure

-$26.00K

Free Cash Flow

-$108.82M

Cash & ST Invst.

$80.22M

Total Debt

$208.00M

Tricida Performance Analysis

Tricida sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42021-12-31N/A
Q12022-03-31N/A
Q22022-06-30N/A
Q32022-09-30N/A
Tricida sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42021-12-31-26.6%
Q12022-03-3145.0%
Q22022-06-303.6%
Q32022-09-309.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q3 2022YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

57

N/A

Net Income

-$27.74M

+30.1%

EBITDA

-$23.71M

+33.4%

Quarterly Fundamentals

Name
Q3 2022YOY CHG

Total Cash

$80.22M

-45.3%

Total Debt

$208.00M

+48.9%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$205.20M

+49.8%

Short Term Debt

$2.80M

+3.0%

Return on Assets

-1.15%

N/A

Return on Invested Capital

-1.14%

N/A

Free Cash Flow

-$18.75M

+35.1%

Operating Cash Flow

-$18.75M

+35.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ENTOEntero Therapeutics, Inc.
$2.85-5.00%
NEUPNeuphoria Therapeutics Inc.
$3.95+8.52%
XAGELongevity Health Holdings Inc.
$0.25+16.21%
XBIOXenetic Biosciences, Inc.
$2.50-5.30%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.28+0.11%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.22-0.03%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$45.95+0.03%
BMNRBitmine Immersion Technologies
$17.65+0.12%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.